Category: Company News

A Major Study About the Acute Treatment of Migraine Using Cefaly Is Published in the Journal of The International Headache Society

Cephalalgia, the official peer-reviewed medical journal of the International Headache Society, has just published positive results of the American multicentric clinical trial ACME (ACute Migraine therapy with External trigeminal neurostimulation: randomized controlled trial) implemented at Yale and Columbia Universities and

Tagged with: , , , , , , , , , , , , , ,

Migraine: Two Published Articles Confirm the Basics of the Cefaly Medical Device

Two new scientific published articles in the peer-reviewed magazine of the International Headache Society, confirm the basic mechanism of the Cefaly® device and detail its effect on the nervous system for the treatment of migraine. The findings confirm remarkable central

Tagged with: , , , , , , , , , , , , ,

Migraine Abortion Phase 3 Trial (TEAM study) with Cefaly® ACUTE Medical Device is Progressing Quickly

The Cefaly® ACUTE medical device, recently cleared by the U.S. Food and Drug Administration (FDA) for the acute treatment of migraine, is the subject of a large phase 3 clinical trial in the United States that is progressing rapidly. Previous

Tagged with: , , , , , , , ,

Chronic Migraine Prevention Trial Shows Positive Results for Cefaly® PREVENT Medical Device

The Cefaly® PREVENT medical device, approved by the U.S. Food and Drug Administration (FDA) for migraine prophylaxis in episodic migraine, was also successful in a recent trial for chronic migraine prevention. Previous pilot and pivotal trials (PREMICE1) demonstrated the efficacy

Tagged with: , , ,

Migraine Abortion Trial Shows Positive Results for Cefaly Acute Medical Device

The Cefaly® Acute medical device, cleared by the U.S. Food and Drug Administration (FDA) two months ago for the acute treatment of migraine with or without aura, was also successful in a recent trial for migraine abortion; and predominantly outperformed

Tagged with: , , , , , , , ,